Sfoglia per ???browse.type.metadata.subjectIsicrui???
Rapid prediction of sustained virological response in patients chronically infected with HCV by evaluation of RNA decay 48h after the start of treatment with pegylated interferon and ribavirin
2010-10-01 Parruti, G; Polilli, E; Sozio, F; Cento, V; Pieri, A; Di Masi, F; Mercurio, F; Tontodonati, M; Mazzotta, E; CECCHERINI SILBERSTEIN, F; Manzoli, L; Perno, Cf
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures
2010-08-15 Trotta, M; Cozzi Lepri, A; Ammassari, A; Vecchiet, J; Cassola, G; Caramello, P; Vullo, V; Soscia, F; Chiodera, A; Ladisa, N; Abeli, C; Cauda, R; Buonuomi, A; Antinori, A; d'Arminio Monforte, A; Perno, Cf
Rational design of MyD88 inhibitors--new pathways to inflammatory control: an interview with Dr. Claudio Sette by Helene F. Rosenberg.
2007-01-01 Sette, C
Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans
2005-04-01 Ventura, N; Rea, S; Henderson, S; Condo', I; Johnson, T; Testi, R
Resistance to novel drug classes
2009-11-01 Marcelin, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Calvez, V
Respiratory viruses and influenza-like illness: a survey in the area of Rome, winter 2004-2005
2006-01-01 Rezza, G; Valdarchi, C; Puzelli, S; Ciotti, M; Farchi, F; Fabiani, C; Calzoletti, L; Donatelli, I; Perno, Cf
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy
2004-01-23 Violin, M; Cozzi Lepri, A; Velleca, R; Vincenti, A; D'Elia, S; Chiodo, F; Ghinelli, F; Bertoli, A; d'Arminio Monforte, A; Perno, Cf; Moroni, M; Balotta, C
Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development
2011-01-01 Svicher, V; Cento, V; Salpini, R; Mercurio, F; Fraune, M; Beggel, B; Han, Y; Gori, C; Wittkop, L; Bertoli, A; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, N; Mazzotta, F; De Sanctis, G; Fleury, H; Trimoulet, P; Angelico, M; Cappiello, G; Zhang, X; Verheyen, J; CECCHERINI SILBERSTEIN, F; Perno, Cf
Roles for p53 and p73 during oligodendrocyte development
2004-01-01 Billon, N; Terrinoni, A; Jolicoeur, C; Mccarthy, A; Richardson, Wd; Melino, G; Raff, M
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence
2011-01-18 Lenci, I; Tisone, G; Di Paolo, D; Marcuccilli, F; Tariciotti, L; Ciotti, M; Svicher, V; Perno, Cf; Angelico, M
Selected Amino Acid Mutations in HIV-1 B Subtype gp41 are Associated with Specific gp120v3 Signatures in the Regulation of Co-Receptor Usage
2011-05-12 Dimonte, S; Mercurio, F; Svicher, V; D'Arrigo, R; Perno, Cf; CECCHERINI SILBERSTEIN, F
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
2011-09-01 Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
2011-09-02 Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
Sequential transmission and long-term persistence of an HIV strain partially resistant to protease inhibitors
2009-04-01 Polilli, E; Di Masi, F; Sozio, F; Mazzotta, E; Alterio, L; Cosentino, L; Clerico, L; Perno, Cf; Parruti, G
Signature mutations in V3 and bridging sheet domain of HIV-1 gp120 are specifically associated with dual tropism and modulate the interaction with CCR5 N-terminus
2011-01-01 Alteri, C; Artese, A; Zang, J; Mercurio, F; Costa, G; Stazi, F; Fabeni, L; Bertoli, A; Forbici, F; Salpini, R; Dimonte, S; Alcaro, S; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection
2011-01-01 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Zhan, J; Verheyen, J; Cappiello, G; Perno, Cf
Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection
2011-01-01 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Salpini, R; Longo, R; Visca, M; Romano, S; Michieli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Verheyen, J; Cappiello, G; Perno, Cf
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors
2010-11-01 CECCHERINI SILBERSTEIN, F; Malet, I; Fabeni, L; Dimonte, S; Svicher, V; D'Arrigo, R; Artese, A; Costa, G; Bono, S; Alcaro, S; Monforte, A; Katlama, C; Calvez, V; Antinori, A; Marcelin, A; Perno, Cf
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment
2006-10-01 Aquaro, S; D'Arrigo, R; Svicher, V; Perri, G; Caputo, S; Visco Comandini, U; Santoro, M; Bertoli, A; Mazzotta, F; Bonora, S; Tozzi, V; Bellagamba, R; Zaccarelli, M; Narciso, P; Antinori, A; Perno, Cf
Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy?
2005-10-14 Antinori, A; Cingolani, A; Perno, Cf
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-ott-2010 | Rapid prediction of sustained virological response in patients chronically infected with HCV by evaluation of RNA decay 48h after the start of treatment with pegylated interferon and ribavirin | Parruti, G; Polilli, E; Sozio, F; Cento, V; Pieri, A; Di Masi, F; Mercurio, F; Tontodonati, M; Mazzotta, E; CECCHERINI SILBERSTEIN, F; Manzoli, L; Perno, Cf | Articolo su rivista | |
15-ago-2010 | Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures | Trotta, M; Cozzi Lepri, A; Ammassari, A; Vecchiet, J; Cassola, G; Caramello, P; Vullo, V; Soscia, F; Chiodera, A; Ladisa, N; Abeli, C; Cauda, R; Buonuomi, A; Antinori, A; d'Arminio Monforte, A; Perno, Cf | Articolo su rivista | |
1-gen-2007 | Rational design of MyD88 inhibitors--new pathways to inflammatory control: an interview with Dr. Claudio Sette by Helene F. Rosenberg. | Sette, C | Articolo su rivista | |
1-apr-2005 | Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans | Ventura, N; Rea, S; Henderson, S; Condo', I; Johnson, T; Testi, R | Articolo su rivista | |
1-nov-2009 | Resistance to novel drug classes | Marcelin, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Calvez, V | Articolo su rivista | |
1-gen-2006 | Respiratory viruses and influenza-like illness: a survey in the area of Rome, winter 2004-2005 | Rezza, G; Valdarchi, C; Puzelli, S; Ciotti, M; Farchi, F; Fabiani, C; Calzoletti, L; Donatelli, I; Perno, Cf | Articolo su rivista | |
23-gen-2004 | Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy | Violin, M; Cozzi Lepri, A; Velleca, R; Vincenti, A; D'Elia, S; Chiodo, F; Ghinelli, F; Bertoli, A; d'Arminio Monforte, A; Perno, Cf; Moroni, M; Balotta, C | Articolo su rivista | |
1-gen-2011 | Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development | Svicher, V; Cento, V; Salpini, R; Mercurio, F; Fraune, M; Beggel, B; Han, Y; Gori, C; Wittkop, L; Bertoli, A; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, N; Mazzotta, F; De Sanctis, G; Fleury, H; Trimoulet, P; Angelico, M; Cappiello, G; Zhang, X; Verheyen, J; CECCHERINI SILBERSTEIN, F; Perno, Cf | Articolo su rivista | |
1-gen-2004 | Roles for p53 and p73 during oligodendrocyte development | Billon, N; Terrinoni, A; Jolicoeur, C; Mccarthy, A; Richardson, Wd; Melino, G; Raff, M | Articolo su rivista | |
18-gen-2011 | Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence | Lenci, I; Tisone, G; Di Paolo, D; Marcuccilli, F; Tariciotti, L; Ciotti, M; Svicher, V; Perno, Cf; Angelico, M | Articolo su rivista | |
12-mag-2011 | Selected Amino Acid Mutations in HIV-1 B Subtype gp41 are Associated with Specific gp120v3 Signatures in the Regulation of Co-Receptor Usage | Dimonte, S; Mercurio, F; Svicher, V; D'Arrigo, R; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
1-set-2011 | 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing | Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
2-set-2011 | 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing | Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
1-apr-2009 | Sequential transmission and long-term persistence of an HIV strain partially resistant to protease inhibitors | Polilli, E; Di Masi, F; Sozio, F; Mazzotta, E; Alterio, L; Cosentino, L; Clerico, L; Perno, Cf; Parruti, G | Articolo su rivista | |
1-gen-2011 | Signature mutations in V3 and bridging sheet domain of HIV-1 gp120 are specifically associated with dual tropism and modulate the interaction with CCR5 N-terminus | Alteri, C; Artese, A; Zang, J; Mercurio, F; Costa, G; Stazi, F; Fabeni, L; Bertoli, A; Forbici, F; Salpini, R; Dimonte, S; Alcaro, S; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V | Intervento a convegno | |
1-gen-2011 | Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Zhan, J; Verheyen, J; Cappiello, G; Perno, Cf | Intervento a convegno | |
1-gen-2011 | Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Salpini, R; Longo, R; Visca, M; Romano, S; Michieli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Verheyen, J; Cappiello, G; Perno, Cf | Intervento a convegno | |
1-nov-2010 | Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors | CECCHERINI SILBERSTEIN, F; Malet, I; Fabeni, L; Dimonte, S; Svicher, V; D'Arrigo, R; Artese, A; Costa, G; Bono, S; Alcaro, S; Monforte, A; Katlama, C; Calvez, V; Antinori, A; Marcelin, A; Perno, Cf | Articolo su rivista | |
1-ott-2006 | Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment | Aquaro, S; D'Arrigo, R; Svicher, V; Perri, G; Caputo, S; Visco Comandini, U; Santoro, M; Bertoli, A; Mazzotta, F; Bonora, S; Tozzi, V; Bellagamba, R; Zaccarelli, M; Narciso, P; Antinori, A; Perno, Cf | Articolo su rivista | |
14-ott-2005 | Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy? | Antinori, A; Cingolani, A; Perno, Cf | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile